NCT00003211View on ClinicalTrials.gov

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1996

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions

Brain and Central Nervous System Tumors

Interventions

BIOLOGICAL

filgrastim

DRUG

amifostine trihydrate

DRUG

cisplatin

DRUG

cyclophosphamide

DRUG

vincristine sulfate

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (4)

2145

Children's Hospital at Westmead, Westmead

3052

Royal Children's Hospital, Parkville

38105

St. Jude Children's Research Hospital, Memphis

77030-2399

Texas Children's Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00003211 - Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor | Biotech Hunter | Biotech Hunter